Articles Archives - Page 319 of 717

FridayDec 10, 2021 9:31 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) New Patent Application Offering Improved Delivery Control, Enhanced Shelf Stability, of Psilocin

The full patent application covers multiple families of psilocin analogs. Psilocin is the active metabolite of psilocybin In addition to improving delivery control, the company’s dermal application route can potentially eliminate undesirable side effects such as nausea Mydecine appoints Dr. Saeid Babaei, PhD, as an independent board member. The appointment can help advance the company’s NASDAQ listing efforts, bringing decades of experience in biotech development and licensing and strategic advancements Company intends to uplist to NASDAQ in Q1 2022 Improving delivery control and shelf stabilization of psilocybin’s active metabolite psilocin, two critical aspects for use in medical settings, is the…

ThursdayDec 09, 2021 2:15 pm

FingerMotion Inc. (FNGR) Research Agreement with Munich Re Sets Stage for Predictive Insurance Analysis Growth

Rich communication services (“RCS”) provider and big data analysis solutions developer FingerMotion has announced an agreement with Munich Re to form a collaborative research alliance to benefit life and health insurance risk evaluation FingerMotion focuses its SMS, MMS, and big data products on China’s huge high-end phone consumer market The company’s most recent quarterly report noted a 25 percent YOY quarterly growth in revenues attributed to SMS and MMS services The Munich Re agreement follows FingerMotion’s contract earlier this year with Pacific Life Reinsurance to provide big data analytical services for Pacific Life’s insurance operations in China Communications and big…

ThursdayDec 09, 2021 1:54 pm

Flora Growth Corp. (NASDAQ: FLGC) Launches European and Mexican Exports of CBD Skincare Brands

Colombian cannabis cultivator and international wellness product builder Flora Growth Corp. is building a global pipeline for its wide array of branded CBD and medicinal cannabis products The company recently announced that it has begun fulfilling the first orders for its Mind Naturals and Awe CBD skincare brands with exports to Spain and Mexico outlets this month Flora Growth cultivates cannabis at its 100-hectare (247-acre) property in central Colombia Flora also has a GMP certified 16,000-square-foot manufacturing facility in Bogota that produces nearly 200 products for the CBD derivatives and medical cannabis markets Cannabis cultivator and worldwide cannabidiol (“CBD”) brand…

ThursdayDec 09, 2021 1:34 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Proceed with its Phase 2a Fibromyalgia Study Following FDA Confirmation

Tryp just announced FDA confirmation for its IND application filed in November 2021 The confirmation allows the company to proceed with its Phase 2a study on the effectiveness of psilocybin-assisted therapy among patients with fibromyalgia This clinical study will be one of the first to evaluate synthetic psilocybin for fibromyalgia in a Phase 2 study It is set to commence in 2022 and will involve 20 fibromyalgia patients Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) just announced that it would be proceeding with its upcoming Phase 2a fibromyalgia study, following a confirmation from the U.S. Food and Drug Administration (“FDA”) (https://ibn.fm/C20cT).…

ThursdayDec 09, 2021 1:24 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Fund, Support First-Ever Psychedelic Treatment Clinic at Manhattan Hospital

Company receives grant to fund clinic for marginalized, underserved NYC communities New clinic will offer psychedelic treatment with no out-of-pocket cost for individuals unable to afford the service Program’s clinicians will receive specialized training Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones in its mission to revolutionize mental healthcare. The company recently received a grant for the first-ever psychedelic treatment clinic at Lenox Hill Hospital (https://ibn.fm/zyerA). Part of Northwell Health, the largest healthcare system in New York State, Lenox Hill Hospital serves marginalized and underserved communities on the Upper East…

WednesdayDec 08, 2021 1:50 pm

American Cannabis Partners’ Strict Adherence to Jamaican Cultivation Techniques Results in Much Sought-After Flower

Jamaican cannabis has benefitted from burgeoning global demand in 2021, with the regulator issuing 42 export licenses American Cannabis Partners has sought to capitalize on growing demand for Jamaican cannabis through a strict adherence to Jamaican cultivation techniques given its close links to the nation US cannabis cultivators are gradually increasing their focus on product differentiation to gain market share within the rapidly growing sector For Jamaican cannabis cultivators, business is booming. The nation’s industry regulator, the Cannabis Licensing Authority (“CLA”), recently revealed that it had witnessed a dramatic uptick in demand for Jamaican ‘ganja’ on the global market, having…

WednesdayDec 08, 2021 1:13 pm

FuelPositive Corp (TSX.V: NHHH) (OTCQB: NHHHF) Issues Costing Model and Timeline for Proprietary Green Ammonia Production System

FuelPositive’s green ammonia production system is affordable, practical, and about to be available for “real-world” applications in the very near future According to the company’s case study, it costs CA$560 to produce one metric tonne of green anhydrous ammonia in Manitoba using its system, compared to the current average Manitoba delivery cost of CA$900 per metric tonne of grey ammonia Having commenced development of the first prototype in June of 2021, FuelPositive has begun the building of its second and third prototypes It expects to deploy pilot systems throughout 2022 FuelPositive expects serial manufacturing to begin in 2023 as batch…

WednesdayDec 08, 2021 1:05 pm

As Older Population Starts Self-Directed Investing, O&G Company Engages SRAX Inc. (NASDAQ: SRAX) for Targeted Outreach

Charles Schwab survey shows 15% of retail investors started during the COVID-19 pandemic in 2020 SRAX’s Sequire premier IR communications platform assists public companies understand and communicate with the investment community After following SRAX to understand its expertise, Sino American Oil Company has engaged SRAX More than 250 companies now use Sequire, driving revenue to $8.3 million in Q3 and on the way to the high-end of 2021 guidance The coronavirus pandemic changed many things in the world, and you can be sure investing is on the list. According to a Charles Schwab survey earlier this year, about 15 percent…

WednesdayDec 08, 2021 12:48 pm

Tingo, Inc. (IWBB) Seeks to Combine Commercial Success and Rural Community Empowerment

Tingo is an Africa-focused agri-fintech company, which seeks to empower rural farming communities through the introduction of innovative farming solutions In addition to driving shareholder returns, the company has also sought to empower societies and produce social upliftment in rural communities in which it is active The company has adopted 5 core sustainable development goals – food security, poverty alleviation, financial inclusion, employment opportunities, & gender equality By the end of the first quarter of 2021, assets under management held within ESG (Environment, Social, Governance) focused funds around the world had ballooned to $1.984 trillion, driven by a global drive…

WednesdayDec 08, 2021 12:27 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals and Therapeutics

Around 40% of available marketed drugs are poorly bioavailable or soluble, and about 90% of New Chemical Entities are known for their low solubility and permeability Lexaria’s patented DehydraTECH(TM) technology offers a solution by improving how APIs (active pharmaceutical ingredients) enter the bloodstream DehydraTECH achieves this by bypassing first-pass-liver metabolism By doing so, Lexaria is facilitating faster and much more thorough drug delivery In a report published in the Bioavailability Enhancement Technologies and Services Market, 2018-2030, it was established that around 40% of available marketed drugs are poorly bioavailable or soluble. It was further estimated that approximately 90% of New…

Site Search

Company Search

Category: Articles